ASSA13-15-18 Efficacy and Safety of Bivalirudin Versus Heparin Plus Glycoprotein IIB/IIIA Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomised Trials

Jiang Long; Cheng Xiaoshu; Yang Renqiang; Fan Yingli; Zhan Rui; Hu Lijuan

doi:10.1136/heartjnl-2013-303992.223

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Browse by collection

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

(15) Interventional Cardiology

ASSA13-15-18 Efficacy and Safety of Bivalirudin Versus Heparin Plus Glycoprotein IIB/IIIA Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomised Trials

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Long J, Xiaoshu C, Renqiang Y, et al

ASSA13-15-18 Efficacy and Safety of Bivalirudin Versus Heparin Plus Glycoprotein IIB/IIIA Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomised Trials

Heart 2013;99:A72.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password